Petr Krejci

Title: **Innovations of Petr Krejci in Pharmaceutical Chemistry**

Introduction

Petr Krejci, a notable inventor based in Olomouc, CZ, has made significant contributions to the field of pharmaceutical chemistry. With one patent to his name, Krejci is recognized for his innovative work on quinoline derivatives, which hold promise for various medical applications.

Latest Patents

Krejci's patent, titled "Derivatives of 2-phenyl-3-hydroxyquinoline-4(1H)-one and methods of their preparation and utilization," focuses on the development of compounds exhibiting useful biological activities. The patent describes derivatives with a complex structure characterized by specific functional groups and the potential for various substitutions. Notably, these compounds have demonstrated cytostatic, cytotoxic, antiproliferation, and immunosuppressive activities, suggesting their relevance in therapeutic applications.

Career Highlights

Petr Krejci is affiliated with Palacký University Olomouc, which highlights his commitment to advancing research in chemistry and pharmacology. His academic background and ongoing research contribute significantly to the understanding of pharmacological substances, paving the way for future drug development.

Collaborations

In his research journey, Krejci has collaborated with notable colleagues, including Pavel Hradil and Jan Hlavac. Their combined expertise enhances the quality and applicability of their work, leading to advancements in the synthesis and utilization of complex chemical compounds.

Conclusion

Petr Krejci's innovative approach to the development of pharmacologically active compounds marks him as a key figure in the realm of pharmaceutical chemistry. His patent highlights the promise of 2-phenyl-3-hydroxyquinoline-4(1H)-one derivatives in drug discovery, underscoring the importance of continued research and collaboration in this dynamic field.